METHYLDOPA DIN 00360252
Health Canada record
| Active ingredient(s) | METHYLDOPA 125 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C02AB02 METHYLDOPA (RACEMIC) |
| Original market date | 02-Apr-1980 |
| Current status date | 04-Apr-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
AA Pharma Inc. — licence 101851, currently licensed, last inspection rating C (2023-05-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHYLDOPA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00360260 | METHYLDOPA | AA PHARMA INC | Tablet | METHYLDOPA 250 MG | Marketed |
| 00426830 | METHYLDOPA | AA PHARMA INC | Tablet | METHYLDOPA 500 MG | Marketed |
| 00016551 | ALDOMET TAB 125MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 125 MG | Cancelled Post Market |
| 00016578 | ALDOMET TAB 250MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00016586 | ALDOMET TAB 500MG | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 500 MG | Cancelled Post Market |
| 00140589 | ALDORIL 15 TAB | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 15 MG | Cancelled Post Market |
| 00140597 | ALDORIL 25 TAB | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 00441708 | APO METHAZIDE 15 | APOTEX INC | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 15 MG | Cancelled Post Market |
| 00441716 | APO METHAZIDE 25 | APOTEX INC | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 00353620 | DOPAMET TAB 125MG | ICN CANADA LTD. | Tablet | METHYLDOPA 125 MG | Cancelled Post Market |
| 00250392 | DOPAMET TAB 250MG | ICN CANADA LTD. | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00353639 | DOPAMET TAB 500MG | ICN CANADA LTD. | Tablet | METHYLDOPA 500 MG | Cancelled Post Market |
| 00385077 | MEDIMET 250TAB | MEDIC LABORATORY LTÉE | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00456365 | METHYLDOPA 125 TAB 125MG | PRO DOC LIMITEE | Tablet | METHYLDOPA 125 MG | Cancelled Post Market |
| 00453714 | METHYLDOPA 250 TAB | PRO DOC LIMITEE | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00456373 | METHYLDOPA 500 TAB 500MG | PRO DOC LIMITEE | Tablet | METHYLDOPA 500 MG | Cancelled Post Market |
| 02232648 | METHYLDOPA TABLETS 125MG | LABORATOIRES CONFAB INC | Tablet | METHYLDOPA 125 MG | Cancelled Pre Market |
| 02232650 | METHYLDOPA TABLETS 250MG | LABORATOIRES CONFAB INC | Tablet | METHYLDOPA 250 MG | Cancelled Pre Market |
| 02232651 | METHYLDOPA TABLETS 500MG | LABORATOIRES CONFAB INC | Tablet | METHYLDOPA 500 MG | Cancelled Pre Market |
| 00363642 | NOVO-DOPARIL 15 TAB | NOVOPHARM LIMITED | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 15 MG | Cancelled Post Market |
| 00363634 | NOVO-DOPARIL 25 TAB | NOVOPHARM LIMITED | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 00337463 | NOVO-MEDOPA TAB 125MG | NOVOPHARM LIMITED | Tablet | METHYLDOPA 125 MG | Cancelled Post Market |
| 00337471 | NOVO-MEDOPA TAB 250MG | NOVOPHARM LIMITED | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00337498 | NOVO-MEDOPA TAB 500MG | NOVOPHARM LIMITED | Tablet | METHYLDOPA 500 MG | Cancelled Post Market |
| 00717517 | NU-MEDOPA TAB 125MG | NU-PHARM INC | Tablet | METHYLDOPA 125 MG | Cancelled Post Market |
| 00717509 | NU-MEDOPA TAB 250MG | NU-PHARM INC | Tablet | METHYLDOPA 250 MG | Cancelled Post Market |
| 00717576 | NU-MEDOPA TAB 500MG | NU-PHARM INC | Tablet | METHYLDOPA 500 MG | Cancelled Post Market |
| 00584967 | PMS-DOPAZIDE 15 TAB | PHARMASCIENCE INC | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 15 MG | Cancelled Post Market |
| 00584975 | PMS-DOPAZIDE-25 TAB | PHARMASCIENCE INC | Tablet | METHYLDOPA 250 MG; HYDROCHLOROTHIAZIDE 25 MG | Cancelled Post Market |
| 00231169 | SUPRES 150 TAB | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 250 MG; CHLOROTHIAZIDE 150 MG | Cancelled Post Market |
| 00231177 | SUPRES 250 TAB | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | Tablet | METHYLDOPA 250 MG; CHLOROTHIAZIDE 250 MG | Cancelled Post Market |
International API supply for METHYLDOPA
4 valid EDQM Certificates of Suitability from 4 holders. 6 active FDA Drug Master Files.
Request a quote for METHYLDOPA